Beyond the Lungs: Heart and Brain Health in BPD
At a Glance
Bronchopulmonary Dysplasia (BPD) can cause complications beyond the lungs, including pulmonary hypertension and white matter injury in the brain. Early screening with echocardiograms and interventions like physical therapy are crucial for supporting your baby's long-term development.
Bronchopulmonary Dysplasia (BPD) is a condition that can affect more than just the lungs. Because the body’s systems are deeply interconnected, the challenges in the lungs can sometimes lead to complications in the heart and the developing brain [1][2]. Understanding these risks allows you and your medical team to monitor your baby closely and start supportive therapies as early as possible.
The Heart-Lung Connection: Pulmonary Hypertension
One of the most significant complications of BPD is Pulmonary Hypertension (PH) [3]. This occurs when the blood pressure in the arteries of the lungs becomes too high.
In a healthy lung, a vast network of tiny blood vessels wraps around the air sacs to pick up oxygen. In BPD, this network is often “simplified” or “pruned,” meaning there are fewer vessels [4][5]. Because there are fewer paths for the blood to travel through, the heart has to pump harder to push blood into the lungs [5][6].
- Screening: Doctors typically screen for PH using an echocardiogram (an ultrasound of the heart) [7]. This is often done around 36 weeks postmenstrual age, but babies with more severe BPD may need multiple scans over time [7][8].
- Impact: If left untreated, PH can cause the right side of the heart to become overworked [6]. However, many babies respond well to treatments like supplemental oxygen and medications (such as sildenafil) that help relax the lung’s blood vessels [9][10].
The Lung-Brain Axis and Neurodevelopment
Researchers have identified what they call the lung-brain axis—a link between the inflammation in a premature baby’s lungs and the health of their developing brain [2].
When the lungs are inflamed or struggling, the body releases chemical signals that can reach the brain [2][11]. This can sometimes lead to white matter injury (also called periventricular leukomalacia or PVL), which affects the “wiring” of the brain that sends messages between different areas [11][12].
What This Means for Development
The risk of developmental delays often correlates with the severity (or Grade) of the BPD [3][13].
- Motor Delays: Some children may experience delays in sitting, crawling, or walking [14].
- Cognitive Impact: There may be challenges with learning or “executive function” (skills like focus and memory) later in childhood [14][15].
- Cerebral Palsy: In more severe cases, particularly those involving significant white matter injury, there is an increased risk of cerebral palsy [16].
The Power of Early Intervention
While these risks can sound frightening, a severe BPD grade at 36 weeks is a clinical tool for resource planning, not a definitive prophecy. Many infants with severe BPD go on to achieve normal cognitive milestones [17][18]. The brain of a premature infant is incredibly plastic, meaning it has a remarkable ability to adapt and form new connections [17].
Knowing these risks is a tool for empowerment. It ensures that your baby will be closely followed by neonatal follow-up clinics and connected with early intervention services like physical, occupational, and speech therapy [19]. These therapies are designed to support your child’s unique developmental path and help them reach their full potential.
Return to the Home Page.
Common questions in this guide
What is the risk of my baby developing pulmonary hypertension with BPD?
How does lung inflammation in BPD affect my baby's brain development?
What treatments are available for pulmonary hypertension in babies with BPD?
What early intervention therapies should we consider for a baby with severe BPD?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my baby's BPD grade, what is the risk of them developing pulmonary hypertension?
- 2.When is the next screening echocardiogram scheduled to check the blood pressure in my baby's lungs?
- 3.Can you explain if my baby has shown signs of white matter injury, and how that might affect their development?
- 4.What early intervention services (like physical or occupational therapy) should we start thinking about now?
- 5.How are we managing my baby's lung inflammation to protect their developing brain?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Bronchopulmonary dysplasia.
Thébaud B, Goss KN, Laughon M, et al.
Nature reviews. Disease primers 2019; (5(1)):78 doi:10.1038/s41572-019-0127-7.
PMID: 31727986 - 2
Perinatal Hyperoxia and Developmental Consequences on the Lung-Brain Axis.
Obst S, Herz J, Alejandre Alcazar MA, et al.
Oxidative medicine and cellular longevity 2022; (2022()):5784146 doi:10.1155/2022/5784146.
PMID: 35251477 - 3
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.
Lagatta JM, Hysinger EB, Zaniletti I, et al.
The Journal of pediatrics 2018; (203()):218-224.e3 doi:10.1016/j.jpeds.2018.07.035.
PMID: 30172426 - 4
Pathogenesis and Physiologic Mechanisms of Neonatal Pulmonary Hypertension: Preclinical Studies.
Young KC, Schmidt AF, Tan AW, et al.
Clinics in perinatology 2024; (51(1)):21-43 doi:10.1016/j.clp.2023.11.004.
PMID: 38325942 - 5
Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
Bui CB, Kolodziej M, Lamanna E, et al.
Frontiers in immunology 2019; (10()):1480 doi:10.3389/fimmu.2019.01480.
PMID: 31354700 - 6
Platelets are indispensable for alveolar development in neonatal mice.
Huang Z, Lin B, Han D, et al.
Frontiers in pediatrics 2022; (10()):943054 doi:10.3389/fped.2022.943054.
PMID: 36016884 - 7
[Clinical features and prognosis of bronchopulmonary dysplasia complicated by pulmonary hypertension in preterm infants].
Wang CH, Shi LP, Ma XL, DU LZ
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2018; (20(11)):893-896.
PMID: 30477618 - 8
Screening for pulmonary hypertension in preterm infants with bronchopulmonary dysplasia: when, how often and does it matter?
Gentle SJ, Carlo WA, Ambalavanan N
Archives of disease in childhood. Fetal and neonatal edition 2026; (111(2)):F177-F182 doi:10.1136/archdischild-2024-328405.
PMID: 40912904 - 9
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists.
Chan S, Brugha R, Quyam S, Moledina S
Breathe (Sheffield, England) 2022; (18(4)):220209 doi:10.1183/20734735.0209-2022.
PMID: 36865938 - 10
Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.
Kadmon G, Schiller O, Dagan T, et al.
Pediatric pulmonology 2017; (52(1)):77-83 doi:10.1002/ppul.23508.
PMID: 27333438 - 11
Hyperoxia-activated circulating extracellular vesicles induce lung and brain injury in neonatal rats.
Ali A, Zambrano R, Duncan MR, et al.
Scientific reports 2021; (11(1)):8791 doi:10.1038/s41598-021-87706-w.
PMID: 33888735 - 12
Corpus Callosum Growth and Neurodevelopmental Outcome Are Negatively Influenced by Systemic Infection in Very Low-Birth-Weight Infants.
Korček P, Korčeková Z, Berka I, et al.
Journal of child neurology 2021; (36(10)):883-887 doi:10.1177/08830738211016239.
PMID: 34048279 - 13
Pulmonary hypertension in preterm neonates with bronchopulmonary dysplasia: a meta-analysis.
Mascarenhas D, Al-Balushi M, Al-Sabahi A, et al.
Archives of disease in childhood. Fetal and neonatal edition 2025; (110(4)):344-352 doi:10.1136/archdischild-2024-327547.
PMID: 39603794 - 14
Pulmonary function and bronchopulmonary dysplasia classification: insights from the Spanish Registry.
Ramos-Navarro C, Sánchez-Luna M, Pérez-Tarazona S, et al.
European journal of pediatrics 2024; (183(9)):3757-3766 doi:10.1007/s00431-024-05629-w.
PMID: 38858227 - 15
Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity.
Kim HR, Jung YH, Kim BI, et al.
Frontiers in pediatrics 2021; (9()):664033 doi:10.3389/fped.2021.664033.
PMID: 34277516 - 16
Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia.
House M, Rowe J, Walters A, et al.
Pediatric pulmonology 2025; (60(9)):e71275 doi:10.1002/ppul.71275.
PMID: 40923652 - 17
Delta like 4 regulates cerebrovascular development and endothelial integrity via DLL4-NOTCH-CLDN5 pathway and is vulnerable to neonatal hyperoxia.
Ke X, Xia S, Yu W, et al.
The Journal of physiology 2024; (602(10)):2265-2285 doi:10.1113/JP285716.
PMID: 38632887 - 18
Comparison of New Bronchopulmonary Dysplasia Definitions on Long-Term Outcomes in Preterm Infants.
Katz TA, van Kaam AH, Schuit E, et al.
The Journal of pediatrics 2023; (253()):86-93.e4 doi:10.1016/j.jpeds.2022.09.022.
PMID: 36150504 - 19
A review and guide to nutritional care of the infant with established bronchopulmonary dysplasia.
Miller AN, Curtiss J, Taylor SN, et al.
Journal of perinatology : official journal of the California Perinatal Association 2023; (43(3)):402-410 doi:10.1038/s41372-022-01578-0.
PMID: 36494567
This page provides educational information about heart and brain complications associated with BPD. It does not replace professional medical advice from your baby's neonatologist or pediatric specialists.
Get notified when new evidence is published on Bronchopulmonary dysplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.